{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:19:09Z","timestamp":1790302749564,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Cystinose Stiftung - Cystinosis Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41431-019-0476-4","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T16:04:20Z","timestamp":1564502660000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-5841","authenticated-orcid":false,"given":"Ludwig","family":"Czibere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2116-0156","authenticated-orcid":false,"given":"Siegfried","family":"Burggraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3459-2326","authenticated-orcid":false,"given":"Tobias","family":"Fleige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Marie","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfert","family":"Landt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Durner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"R\u00f6schinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunhilde","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Vill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"476_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","volume":"39","author":"BL Therrell","year":"2015","unstructured":"Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJ, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39:171\u201387.","journal-title":"Semin Perinatol."},{"key":"476_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000272898","volume":"14","author":"A Andermann","year":"2011","unstructured":"Andermann A, Blancquaert I, Beauchamp S, Costea I. Guiding policy decisions for genetic screening: developing a systematic and transparent approach. Public Health Genom. 2011;14:9\u201316.","journal-title":"Public Health Genom."},{"key":"476_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2471\/BLT.07.050112","volume":"86","author":"A Andermann","year":"2008","unstructured":"Andermann A, Blancquaert I, Beauchamp S, Dery V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008;86:317\u20139.","journal-title":"Bull World Health Organ"},{"key":"476_CR4","doi-asserted-by":"publisher","first-page":"E422","DOI":"10.1503\/cmaj.171154","volume":"190","author":"MJ Dobrow","year":"2018","unstructured":"Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ 2018;190:E422\u20139.","journal-title":"CMAJ"},{"key":"476_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28:197\u2013207.","journal-title":"Neuromuscul Disord."},{"key":"476_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103\u201315.","journal-title":"Neuromuscul Disord."},{"key":"476_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20:27\u201332.","journal-title":"Eur J Hum Genet."},{"key":"476_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","volume":"264","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Leary R, McMacken G, Konig K, Kirschner J, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264:1465\u201373.","journal-title":"J Neurol."},{"key":"476_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358\u201368.","journal-title":"Am J Hum Genet."},{"key":"476_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/01.gim.0000227970.60450.b2","volume":"8","author":"RE Pyatt","year":"2006","unstructured":"Pyatt RE, Prior TW. A feasibility study for the newborn screening of spinal muscular atrophy. Genet Med. 2006;8:428\u201337.","journal-title":"Genet Med."},{"key":"476_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365.","journal-title":"Cell."},{"key":"476_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15:228\u201337.","journal-title":"Hum Mutat."},{"key":"476_CR13","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/ajmg.a.33474","volume":"152A","author":"TW Prior","year":"2010","unstructured":"Prior TW, Snyder PJ, Rink BD, Pearl DK, Pyatt RE, Mihal DC, et al. Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A. 2010;152A:1608\u201316.","journal-title":"Am J Med Genet A."},{"key":"476_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1086\/301608","volume":"61","author":"B Wirth","year":"1997","unstructured":"Wirth B, Schmidt T, Hahnen E, Rudnik-Schoneborn S, Krawczak M, Muller-Myhsok B, et al. De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet. 1997;61:1102\u201311.","journal-title":"Am J Hum Genet."},{"key":"476_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1086\/302369","volume":"64","author":"B Wirth","year":"1999","unstructured":"Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik-Schoneborn S, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet. 1999;64:1340\u201356.","journal-title":"Am J Hum Genet."},{"key":"476_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33:831\u201346.","journal-title":"Neurol Clin."},{"key":"476_CR17","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet. 2016;388:3017\u201326.","journal-title":"Lancet."},{"issue":"9","key":"476_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/jcm7090251","volume":"7","author":"Sonia Messina","year":"2018","unstructured":"Messina S. New directions for SMA therapy. J Clin Med. 2018;7:251.","journal-title":"Journal of Clinical Medicine"},{"key":"476_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1089\/gte.2008.0014","volume":"12","author":"MA Alcantara-Ortigoza","year":"2008","unstructured":"Alcantara-Ortigoza MA, Belmont-Martinez L, Vela-Amieva M, Gonzalez-Del Angel A. Analysis of the CTNS gene in nephropathic cystinosis Mexican patients: report of four novel mutations and identification of a false positive 57-kb deletion genotype with LDM-2\/exon 4 multiplex PCR assay. Genet Test. 2008;12:409\u201314.","journal-title":"Genet Test."},{"key":"476_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. N Engl J Med. 2018;378:625\u201335.","journal-title":"N Engl J Med."},{"key":"476_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/acn3.689","volume":"6","author":"A Saffari","year":"2019","unstructured":"Saffari A, Kolker S, Hoffmann GF, Weiler M, Ziegler A. Novel challenges in spinal muscular atrophy - How to screen and whom to treat? Ann Clin Transl Neurol. 2019;6:197\u2013205.","journal-title":"Ann Clin Transl Neurol."},{"key":"476_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","volume":"190","author":"YH Chien","year":"2017","unstructured":"Chien YH, Chiang SC, Weng WC, Lee NC, Lin CJ, Hsieh WS, et al. Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J Pediatr. 2017;190:124\u20139.","journal-title":"J Pediatr."},{"key":"476_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4236\/ojgen.2013.32014","volume":"3","author":"CM Strom","year":"2013","unstructured":"Strom CM, Anderson B, Peng M, Patel U, Braastad CD, Sun W. 1000 sample comparison of MLPA and RT-PCR for carrier detection and diagnostic testing for spinal muscular atrophy type 1. Open J Genet. 2013;3:111\u20134.","journal-title":"Open J Genet."},{"key":"476_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.nmd.2006.08.011","volume":"16","author":"EL Arkblad","year":"2006","unstructured":"Arkblad EL, Darin N, Berg K, Kimber E, Brandberg G, Lindberg C, et al. Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy. Neuromuscul Disord. 2006;16:830\u20138.","journal-title":"Neuromuscul Disord."},{"key":"476_CR25","first-page":"563","volume":"35","author":"HT Forst","year":"1985","unstructured":"Forst HT. Problems of multiple tests and evaluations in drug research. Arzneim Forsch. 1985;35:563\u20139.","journal-title":"Arzneim Forsch."},{"key":"476_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.semperi.2015.03.006","volume":"39","author":"HC Phan","year":"2015","unstructured":"Phan HC, Taylor JL, Hannon H, Howell R. Newborn screening for spinal muscular atrophy: anticipating an imminent need. Semin Perinatol. 2015;39:217\u201329.","journal-title":"Semin Perinatol."},{"key":"476_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/anie.200903363","volume":"49","author":"J Durner","year":"2010","unstructured":"Durner J. Clinical chemistry: challenges for analytical chemistry and the nanosciences from medicine. Angew Chem Int Ed Engl. 2010;49:1026\u201351.","journal-title":"Angew Chem Int Ed Engl."},{"key":"476_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1373\/clinchem.2012.198945","volume":"59","author":"CA Saavedra-Matiz","year":"2013","unstructured":"Saavedra-Matiz CA, Isabelle JT, Biski CK, Duva SJ, Sweeney ML, Parker AL, et al. Cost-effective and scalable DNA extraction method from dried blood spots. Clin Chem. 2013;59:1045\u201351.","journal-title":"Clin Chem."},{"key":"476_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/gim.2017.152","volume":"20","author":"JN Kraszewski","year":"2018","unstructured":"Kraszewski JN, Kay DM, Stevens CF, Koval C, Haser B, Ortiz V, et al. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state. Genet Med. 2018;20:608\u201313.","journal-title":"Genet Med."},{"key":"476_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1373\/clinchem.2014.231019","volume":"61","author":"JL Taylor","year":"2015","unstructured":"Taylor JL, Lee FK, Yazdanpanah GK, Staropoli JF, Liu M, Carulli JP, et al. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency. Clin Chem. 2015;61:412\u20139.","journal-title":"Clin Chem."},{"key":"476_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.braindev.2017.06.002","volume":"39","author":"M Ar Rochmah","year":"2017","unstructured":"Ar Rochmah M, Awano H, Awaya T, Harahap NIF, Morisada N, Bouike Y, et al. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA. Brain Dev. 2017;39:851\u201360.","journal-title":"Brain Dev."},{"key":"476_CR32","doi-asserted-by":"publisher","first-page":"e0195740","DOI":"10.1371\/journal.pone.0195740","volume":"13","author":"Z Hao","year":"2018","unstructured":"Hao Z, Fu D, Ming Y, Yang J, Huang Q, Lin W, et al. Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China. PLoS ONE. 2018;13:e0195740.","journal-title":"PLoS ONE."},{"key":"476_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/sj.ejhg.5201821","volume":"15","author":"M Smith","year":"2007","unstructured":"Smith M, Calabro V, Chong B, Gardiner N, Cowie S, du Sart D. Population screening and cascade testing for carriers of SMA. Eur J Hum Genet. 2007;15:759\u201366.","journal-title":"Eur J Hum Genet."},{"key":"476_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","volume":"28","author":"M Calucho","year":"2018","unstructured":"Calucho M, Bernal S, Alias L, March F, Vencesla A, Rodriguez-Alvarez FJ, et al. Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases. Neuromuscul Disord. 2018;28:208\u201315.","journal-title":"Neuromuscul Disord."},{"key":"476_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","volume":"320","author":"GE Oprea","year":"2008","unstructured":"Oprea GE, Krober S, McWhorter ML, Rossoll W, Muller S, Krawczak M, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science. 2008;320:524\u20137.","journal-title":"Science."},{"key":"476_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","volume":"27","author":"ST Crooke","year":"2018","unstructured":"Crooke ST, Witztum JL, Bennett CF, Baker BF. RNA-targeted therapeutics. Cell Metab. 2018;27:714\u201339.","journal-title":"Cell Metab."},{"key":"476_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JND-180304","volume":"5","author":"J Glascock","year":"2018","unstructured":"Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, et al. Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening. J Neuromuscul Dis. 2018;5:145\u201358.","journal-title":"J Neuromuscul Dis."},{"key":"476_CR38","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713\u201322.","journal-title":"N Engl J Med."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0476-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-019-0476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:00:18Z","timestamp":1684616418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-019-0476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1038\/s41431-019-0476-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}